产品展示更多>>
- SYR472 1029877-94-8
- SYR472 1029877-94-8
SYR472 1029877-94-8
产品描述 描述 Trelagliptin(SYR-472) is a long acting dipeptidyl peptidase-4 (DPP-4) inhibitor that is being developed for the treatment of type 2 diabetes (T2D).纯度 99%储存/保存方法 Store at -20℃ for one year（Powder）；Store at 2-4℃ for two weeks；Store at -20℃ for six months after dissolution.基本信息 可溶性/溶解性 10 mM in DMSO生物活性 靶点 Dipeptidyl Peptidase参考文献 参考文献 1. McKeage K. Drugs. 2015 Jul;75(10):1161-4.
2. Inagaki N, et al. Lancet Diabetes Endocrinol. 2015 Mar;3(3):191-7.
研究领域 研究领域 CancerCancer MetabolismResponse to hypoxiaProteolysis / UbiquitinProteolytic enzymesSerine proteaseDPPsImmunologyAdaptive ImmunityB CellsCDImmunologyAdaptive ImmunityT CellsCDImmunologyCell Type MarkersCDAdhesionImmunologyCell Type MarkersCDNon-lineageImmunologyImmune System DiseasesAntiviral SignalingHIV-relatedMetabolismPathways and ProcessesMetabolism processesHypoxiaMicrobiologyOrganismVirusDNA VirusssRNA positive strand virusSARS CoronavirusStem CellsHematopoietic ProgenitorsLymphoidB Lymphocytic LineageStem CellsHematopoietic ProgenitorsLymphoidT Lymphocytic LineageDrug DiscoverySmall Molecule DrugLead Compound DiscoverySYR472 1029877-94-8温馨提示：本产品仅作科研实验使用，不支持临床等研究